UBS Group’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.43M Buy
363,848
+315,089
+646% +$6.43M ﹤0.01% 2705
2025
Q1
$976K Sell
48,759
-763,841
-94% -$15.3M ﹤0.01% 4205
2024
Q4
$21.7M Buy
812,600
+758,466
+1,401% +$20.2M ﹤0.01% 1692
2024
Q3
$1.54M Buy
54,134
+5,411
+11% +$154K ﹤0.01% 3233
2024
Q2
$1.06M Sell
48,723
-6,120
-11% -$133K ﹤0.01% 3361
2024
Q1
$1.21M Buy
54,843
+13,366
+32% +$296K ﹤0.01% 3414
2023
Q4
$895K Buy
41,477
+23,436
+130% +$506K ﹤0.01% 3522
2023
Q3
$305K Buy
18,041
+736
+4% +$12.4K ﹤0.01% 3959
2023
Q2
$237K Buy
17,305
+6,731
+64% +$92.3K ﹤0.01% 4343
2023
Q1
$240K Buy
10,574
+89
+0.8% +$2.02K ﹤0.01% 4219
2022
Q4
$247K Buy
10,485
+3,354
+47% +$79K ﹤0.01% 4222
2022
Q3
$186K Sell
7,131
-9,094
-56% -$237K ﹤0.01% 4127
2022
Q2
$356K Buy
16,225
+12,376
+322% +$272K ﹤0.01% 3583
2022
Q1
$173K Sell
3,849
-6,549
-63% -$294K ﹤0.01% 4489
2021
Q4
$446K Buy
10,398
+9,142
+728% +$392K ﹤0.01% 4061
2021
Q3
$83K Buy
1,256
+576
+85% +$38.1K ﹤0.01% 4875
2021
Q2
$50K Sell
680
-8,497
-93% -$625K ﹤0.01% 5365
2021
Q1
$628K Sell
9,177
-1,966
-18% -$135K ﹤0.01% 3765
2020
Q4
$748K Buy
11,143
+7,121
+177% +$478K ﹤0.01% 3364
2020
Q3
$206K Sell
4,022
-2,229
-36% -$114K ﹤0.01% 3968
2020
Q2
$236K Sell
6,251
-432
-6% -$16.3K ﹤0.01% 3891
2020
Q1
$199K Buy
6,683
+1,490
+29% +$44.4K ﹤0.01% 3898
2019
Q4
$178K Buy
5,193
+2,383
+85% +$81.7K ﹤0.01% 4663
2019
Q3
$51K Buy
+2,810
New +$51K ﹤0.01% 5247